nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A5—dilated cardiomyopathy	0.27	0.342	CbGaD
Epinephrine—ADRB1—dilated cardiomyopathy	0.187	0.236	CbGaD
Epinephrine—TNF—dilated cardiomyopathy	0.177	0.224	CbGaD
Epinephrine—ADRB2—dilated cardiomyopathy	0.157	0.198	CbGaD
Epinephrine—SLC22A5—Furosemide—dilated cardiomyopathy	0.0618	1	CbGbCtD
Epinephrine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00578	0.357	CbGeAlD
Epinephrine—ADRBK1—myocardium—dilated cardiomyopathy	0.00176	0.109	CbGeAlD
Epinephrine—Local reaction—Furosemide—dilated cardiomyopathy	0.00161	0.0603	CcSEcCtD
Epinephrine—ADRBK1—heart—dilated cardiomyopathy	0.00123	0.0759	CbGeAlD
Epinephrine—Drug interaction—Furosemide—dilated cardiomyopathy	0.000963	0.036	CcSEcCtD
Epinephrine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000918	0.0343	CcSEcCtD
Epinephrine—Renal failure—Spironolactone—dilated cardiomyopathy	0.000903	0.0337	CcSEcCtD
Epinephrine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000875	0.0327	CcSEcCtD
Epinephrine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000854	0.0319	CcSEcCtD
Epinephrine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000799	0.0299	CcSEcCtD
Epinephrine—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.000784	0.0484	CbGeAlD
Epinephrine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000742	0.0277	CcSEcCtD
Epinephrine—ADRB1—myocardium—dilated cardiomyopathy	0.000737	0.0455	CbGeAlD
Epinephrine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000722	0.027	CcSEcCtD
Epinephrine—Orciprenaline—ADRB2—dilated cardiomyopathy	0.00069	0.0948	CrCbGaD
Epinephrine—Pirbuterol—ADRB1—dilated cardiomyopathy	0.000661	0.0909	CrCbGaD
Epinephrine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.0006	0.0224	CcSEcCtD
Epinephrine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000597	0.0223	CcSEcCtD
Epinephrine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.000591	0.0365	CbGeAlD
Epinephrine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00059	0.022	CcSEcCtD
Epinephrine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000566	0.0349	CbGeAlD
Epinephrine—Pirbuterol—ADRB2—dilated cardiomyopathy	0.000556	0.0764	CrCbGaD
Epinephrine—ADRA2C—myocardium—dilated cardiomyopathy	0.000555	0.0343	CbGeAlD
Epinephrine—SLC22A5—myocardium—dilated cardiomyopathy	0.000532	0.0328	CbGeAlD
Epinephrine—Dipivefrin—ADRB2—dilated cardiomyopathy	0.000523	0.0718	CrCbGaD
Epinephrine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000521	0.0195	CcSEcCtD
Epinephrine—Isoetarine—ADRB1—dilated cardiomyopathy	0.000519	0.0713	CrCbGaD
Epinephrine—ADRB1—heart—dilated cardiomyopathy	0.000515	0.0318	CbGeAlD
Epinephrine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000511	0.0191	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000506	0.0189	CcSEcCtD
Epinephrine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000506	0.0189	CcSEcCtD
Epinephrine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0005	0.0187	CcSEcCtD
Epinephrine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000499	0.0186	CcSEcCtD
Epinephrine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000496	0.0185	CcSEcCtD
Epinephrine—Renal failure—Furosemide—dilated cardiomyopathy	0.000491	0.0184	CcSEcCtD
Epinephrine—Sweating—Furosemide—dilated cardiomyopathy	0.000479	0.0179	CcSEcCtD
Epinephrine—Terbutaline—ADRB2—dilated cardiomyopathy	0.000453	0.0623	CrCbGaD
Epinephrine—ADRB1—cardiac atrium—dilated cardiomyopathy	0.00044	0.0272	CbGeAlD
Epinephrine—Isoetarine—ADRB2—dilated cardiomyopathy	0.000436	0.06	CrCbGaD
Epinephrine—Arbutamine—ADRB1—dilated cardiomyopathy	0.000413	0.0567	CrCbGaD
Epinephrine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00041	0.0153	CcSEcCtD
Epinephrine—ADRA1A—heart—dilated cardiomyopathy	0.000407	0.0251	CbGeAlD
Epinephrine—Salbutamol—ADRB1—dilated cardiomyopathy	0.000401	0.055	CrCbGaD
Epinephrine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000401	0.015	CcSEcCtD
Epinephrine—Erythema—Furosemide—dilated cardiomyopathy	0.00039	0.0146	CcSEcCtD
Epinephrine—ADRA2C—heart—dilated cardiomyopathy	0.000388	0.0239	CbGeAlD
Epinephrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000387	0.0145	CcSEcCtD
Epinephrine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000379	0.0142	CcSEcCtD
Epinephrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000372	0.0139	CcSEcCtD
Epinephrine—SLC22A5—heart—dilated cardiomyopathy	0.000371	0.0229	CbGeAlD
Epinephrine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00037	0.0138	CcSEcCtD
Epinephrine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000369	0.0138	CcSEcCtD
Epinephrine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000367	0.0137	CcSEcCtD
Epinephrine—Sweating—Lisinopril—dilated cardiomyopathy	0.000359	0.0134	CcSEcCtD
Epinephrine—Agitation—Furosemide—dilated cardiomyopathy	0.000359	0.0134	CcSEcCtD
Epinephrine—Nausea—Spironolactone—dilated cardiomyopathy	0.000348	0.013	CcSEcCtD
Epinephrine—Arbutamine—ADRB2—dilated cardiomyopathy	0.000347	0.0477	CrCbGaD
Epinephrine—Salbutamol—ADRB2—dilated cardiomyopathy	0.000337	0.0463	CrCbGaD
Epinephrine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000335	0.0125	CcSEcCtD
Epinephrine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000332	0.0205	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00033	0.0123	CcSEcCtD
Epinephrine—CYP2C9—heart—dilated cardiomyopathy	0.000319	0.0197	CbGeAlD
Epinephrine—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000318	0.0196	CbGeAlD
Epinephrine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000313	0.0117	CcSEcCtD
Epinephrine—Flushing—Lisinopril—dilated cardiomyopathy	0.000312	0.0117	CcSEcCtD
Epinephrine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00031	0.0116	CcSEcCtD
Epinephrine—ADRA2A—heart—dilated cardiomyopathy	0.000309	0.0191	CbGeAlD
Epinephrine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000308	0.0115	CcSEcCtD
Epinephrine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000301	0.0112	CcSEcCtD
Epinephrine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000295	0.011	CcSEcCtD
Epinephrine—Erythema—Lisinopril—dilated cardiomyopathy	0.000293	0.0109	CcSEcCtD
Epinephrine—Norepinephrine—SLC22A5—dilated cardiomyopathy	0.000289	0.0397	CrCbGaD
Epinephrine—Tension—Lisinopril—dilated cardiomyopathy	0.000288	0.0107	CcSEcCtD
Epinephrine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000286	0.0107	CcSEcCtD
Epinephrine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000285	0.0106	CcSEcCtD
Epinephrine—Somnolence—Furosemide—dilated cardiomyopathy	0.000283	0.0106	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000275	0.0103	CcSEcCtD
Epinephrine—Dopamine—SLC22A5—dilated cardiomyopathy	0.000269	0.0369	CrCbGaD
Epinephrine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000265	0.0163	CbGeAlD
Epinephrine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000259	0.00967	CcSEcCtD
Epinephrine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000249	0.00932	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000248	0.00925	CcSEcCtD
Epinephrine—Droxidopa—ADRB1—dilated cardiomyopathy	0.000237	0.0326	CrCbGaD
Epinephrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000233	0.00872	CcSEcCtD
Epinephrine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000232	0.00868	CcSEcCtD
Epinephrine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000231	0.00864	CcSEcCtD
Epinephrine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000216	0.00808	CcSEcCtD
Epinephrine—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000216	0.0296	CrCbGaD
Epinephrine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000215	0.00802	CcSEcCtD
Epinephrine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000213	0.00794	CcSEcCtD
Epinephrine—Dizziness—Furosemide—dilated cardiomyopathy	0.000211	0.00787	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000206	0.00771	CcSEcCtD
Epinephrine—Vomiting—Furosemide—dilated cardiomyopathy	0.000203	0.00757	CcSEcCtD
Epinephrine—Norepinephrine—ADRB1—dilated cardiomyopathy	0.0002	0.0274	CrCbGaD
Epinephrine—Droxidopa—ADRB2—dilated cardiomyopathy	0.000199	0.0274	CrCbGaD
Epinephrine—Nausea—Furosemide—dilated cardiomyopathy	0.000189	0.00707	CcSEcCtD
Epinephrine—Dopamine—ADRB1—dilated cardiomyopathy	0.000186	0.0255	CrCbGaD
Epinephrine—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000181	0.0249	CrCbGaD
Epinephrine—Norepinephrine—ADRB2—dilated cardiomyopathy	0.000168	0.0231	CrCbGaD
Epinephrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000158	0.00591	CcSEcCtD
Epinephrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000152	0.00568	CcSEcCtD
Epinephrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000142	0.00531	CcSEcCtD
Epinephrine—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.35e-05	0.000242	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.33e-05	0.000241	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.33e-05	0.000241	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.33e-05	0.00024	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.33e-05	0.00024	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.31e-05	0.000238	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.28e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.28e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.28e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.26e-05	0.000233	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.26e-05	0.000233	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.25e-05	0.000233	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.24e-05	0.000231	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	2.23e-05	0.00023	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—RAF1—dilated cardiomyopathy	2.23e-05	0.00023	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.22e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	2.22e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.21e-05	0.000228	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.2e-05	0.000227	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.19e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.19e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.17e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.17e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.16e-05	0.000223	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.15e-05	0.000222	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.14e-05	0.000221	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.12e-05	0.000218	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.12e-05	0.000218	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.12e-05	0.000218	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.12e-05	0.000218	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.1e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.09e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	2.09e-05	0.000215	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.07e-05	0.000214	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.06e-05	0.000213	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.05e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.05e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.05e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.04e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.03e-05	0.00021	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.03e-05	0.000209	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—RAF1—dilated cardiomyopathy	2.03e-05	0.000209	CbGpPWpGaD
Epinephrine—PAH—Disease—EGFR—dilated cardiomyopathy	2.01e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2e-05	0.000207	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.98e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.97e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.97e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.93e-05	0.000199	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.93e-05	0.000199	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.9e-05	0.000197	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.9e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AGT—dilated cardiomyopathy	1.89e-05	0.000195	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.87e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.87e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—RAF1—dilated cardiomyopathy	1.87e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.87e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.86e-05	0.000191	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.84e-05	0.00019	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.83e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.83e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	1.82e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.82e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.82e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.79e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.78e-05	0.000184	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.76e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.76e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.75e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.75e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.74e-05	0.000179	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.73e-05	0.000179	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.72e-05	0.000177	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.71e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	1.7e-05	0.000176	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.7e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.7e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.7e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.68e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	1.67e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.66e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.66e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.66e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.66e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.65e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.65e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.64e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.64e-05	0.000169	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.63e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.63e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.63e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.62e-05	0.000168	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.6e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.6e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.59e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.59e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.58e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.56e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.55e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.55e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.54e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.54e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.54e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.53e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.53e-05	0.000158	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—EGFR—dilated cardiomyopathy	1.53e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.52e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.52e-05	0.000157	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.52e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	1.52e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.51e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.51e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.51e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.51e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.51e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.49e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.48e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.48e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.46e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.45e-05	0.00015	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.45e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.43e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.42e-05	0.000147	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.41e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.41e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.41e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.41e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.4e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EGFR—dilated cardiomyopathy	1.39e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.39e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.39e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.38e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.36e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.36e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.35e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.35e-05	0.000139	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.34e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.33e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.32e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.31e-05	0.000135	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.3e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.29e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EGFR—dilated cardiomyopathy	1.28e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.28e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.27e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.26e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.25e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.25e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.25e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.25e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.23e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.22e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.21e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.21e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.2e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.2e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.18e-05	0.000122	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.17e-05	0.000121	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.17e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.16e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.16e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.16e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.14e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.14e-05	0.000118	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.14e-05	0.000118	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.14e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.13e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.12e-05	0.000116	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.11e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.1e-05	0.000114	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.09e-05	0.000112	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.06e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.06e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.05e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.04e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.03e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.03e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.03e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.03e-05	0.000107	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.02e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.02e-05	0.000105	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	9.96e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	9.87e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.81e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.78e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.65e-06	9.95e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.63e-06	9.94e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.61e-06	9.92e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	9.54e-06	9.85e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.49e-06	9.8e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.42e-06	9.72e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	9.33e-06	9.63e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	9.22e-06	9.52e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.21e-06	9.5e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.12e-06	9.41e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	9e-06	9.28e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.98e-06	9.27e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	8.98e-06	9.27e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	8.91e-06	9.2e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	8.8e-06	9.08e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	8.71e-06	8.99e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	8.58e-06	8.85e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.55e-06	8.82e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.43e-06	8.7e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	8.33e-06	8.59e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	8.19e-06	8.46e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	8.09e-06	8.35e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.95e-06	8.21e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.95e-06	8.2e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.83e-06	8.09e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.62e-06	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	7.28e-06	7.51e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.25e-06	7.48e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.21e-06	7.44e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.18e-06	7.41e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.09e-06	7.32e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.08e-06	7.3e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	6.85e-06	7.07e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.76e-06	6.98e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.71e-06	6.92e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.6e-06	6.81e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.24e-06	6.44e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.19e-06	6.38e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.11e-06	6.3e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.96e-06	6.15e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.86e-06	6.05e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.8e-06	5.99e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	5.78e-06	5.96e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	5.69e-06	5.87e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.45e-06	5.62e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.22e-06	5.39e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.09e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.05e-06	5.21e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.96e-06	5.12e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	4.7e-06	4.85e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.69e-06	4.84e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.46e-06	4.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.28e-06	4.42e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.24e-06	4.38e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.19e-06	4.32e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.96e-06	4.09e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.93e-06	4.06e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.9e-06	4.02e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.83e-06	3.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.46e-06	3.57e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.45e-06	3.56e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.22e-06	3.32e-05	CbGpPWpGaD
